Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anna V. Karaseva"'
Autor:
Ekaterina I. Alexeeva, Tatiana M. Dvoryakovskaya, Rina V. Denisova, Olga L. Lomakina, Anna V. Karaseva
Publikováno v:
Вопросы современной педиатрии, Vol 16, Iss 4, Pp 314-320 (2017)
The article presents a case of a severe progressive course of polyarticular juvenile idiopathic arthritis, debuting at an early age, refractory to the therapy with methotrexate, cyclosporine, and glucocorticosteroids. A clinical example demonstrates
Externí odkaz:
https://doaj.org/article/2b6eb48eb93442c999dbab56dd8a1515
Publikováno v:
Вопросы современной педиатрии, Vol 16, Iss 4, Pp 321-325 (2017)
The article presents a case of polyarticular juvenile idiopathic arthritis resistant to methotrexate therapy and nonsteroidal antiinflammatory drugs. The child was prescribed a tumor necrosis factor inhibitor etanercept at a dose of 0.4 mg/kg body we
Externí odkaz:
https://doaj.org/article/bc3d972fbf674b66920c3c7155ecbc67
Autor:
Ekaterina I. Alexeeva, Leyla S. Namazova-Baranova, Tatyana M. Bzarova, Saniya I. Valieva, Rina V. Denisova, Tatyana V. Sleptsova, Kseniya B. Isaeva, Alexandra M. Chomahidze, Nikolay I. Taibulatov, Anna N. Fetisova, Anna V. Karaseva, Alexandr A. Baranov
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 15, Iss 1, Pp 1-11 (2017)
Abstract Background The aim of this study was to investigate the efficacy of etanercept treatment and to identify predictors of response to therapy within 12 months in patients with juvenile idiopathic arthritis (JIA) without systemic manifestations.
Externí odkaz:
https://doaj.org/article/2127ac0e78d44a4dbc8dd9e6b0d0ee5b
Autor:
Margarita A. Soloshenko, Ekaterina I. Alekseeva, Tatiana M. Bzarova, Kseniya B. Isaeva, Rina V. Denisova, Olga L. Lomakina, Elena M. Kaschenko, Anna V. Karaseva
Publikováno v:
Вопросы современной педиатрии, Vol 16, Iss 1, Pp 24-28 (2017)
This review summarizes the international experience of pneumococcal immunization of patients with juvenile idiopathic arthritis (JIA). The high efficiency and safety of pneumococcal vaccines in children with JIA is shown. Numerous studies have demons
Externí odkaz:
https://doaj.org/article/c3237b8c1a594bdbaccfba11cd68e945
Autor:
Ekaterina I. Alekseeva, Тatyana М. Bzarova, Saniya I. Valieva, Rina V. Denisova, Kseniya B. Isaeva, Evgenia G. Chistyakova, Alexandra M. Chomahidze, Tatyana V. Sleptsova, Anna N. Fetisova, Оlga L. Lomakina, Nikolay I. Taybulatov, Anna V. Karaseva
Publikováno v:
Вопросы современной педиатрии, Vol 15, Iss 5, Pp 471-480 (2016)
Background: Addition of genetically engineered biological agents in the paradigm of juvenile idiopathic arthritis (JIA) treatment significantly increased the efficacy of the antirheumatic therapy in patients with this severe chronic disease. Objectiv
Externí odkaz:
https://doaj.org/article/70c30bd358c94f0b8388119ab728446e
Autor:
Leyla Namazova-Baranova, A.A. Baranov, Alexandra Chomahidze, Rina Denisova, K. Isaeva, T. Sleptsova, S. I. Valieva, Anna V. Karaseva, Ekaterina Alexeeva, A. Fetisova, T. Bzarova, Nikolay I. Taibulatov
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 15, Iss 1, Pp 1-11 (2017)
Pediatric Rheumatology Online Journal
Pediatric Rheumatology Online Journal
Background The aim of this study was to investigate the efficacy of etanercept treatment and to identify predictors of response to therapy within 12 months in patients with juvenile idiopathic arthritis (JIA) without systemic manifestations. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::346456f420e13626550ca125a65b92cb
https://doi.org/10.1186/s12969-017-0178-9
https://doi.org/10.1186/s12969-017-0178-9